Revenue (Q4 2025): $134.3 million, 19.3% organic growth year-over-year. Revenue (Full Year 2025): $489.7 million, 11.5% increase over 2024. Adjusted EBITDA Margin (Q4 2025): 18.4%. Adjusted Profit ...

CI&T Inc. (CINT) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.08 per share a year ago. These figures are ...

CI&T Inc. (CINT) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook gives ...

The start-up Function will send practically anyone to a lab for extensive medical testing, no physical required. Is that a good thing? By Kristen V. Brown As Kimberly Crisp approached middle age, ...

CI&T Inc (NYSE:CINT) is one of the best affordable stocks under $5 to buy for the next 3 years. CI&T Inc (NYSE:CINT) announced on December 5 that CFO Niels Boon would be transitioning out of the role ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

Function Health, a startup that offers lab testing and body scans for early disease detection, scored nearly $300 million in series B funding, boosting its valuation to $2.5 billion. Redpoint Ventures ...

Fintel reports that on November 13, 2025, Canaccord Genuity maintained coverage of CI&T (NYSE:CINT) with a Buy recommendation. Analyst Price Forecast Suggests 59.36% Upside As of November 9, 2025, the ...

Working from his suburban St. Charles Parish home, and from his stylish office in New Orleans' Lower Garden District, he's the unlikely CEO of Cint, the Stockholm-based company that bought his ...

NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Cint, a global leader in research and measurement technology, and Affinity Solutions, the leading consumer purchase insights company, today announced a ...